Namaste
27-10-2020
Business Standard
Ø India begins anti-dumping probe into low density polyethylene imports from US, UAE, others
Ø RBI's regulation to improve risk management, governance of HFCs: Experts
Ø 75% of borrowers to benefit from interest concession: CRISIL
Ø India will drive global energy demand: PM Narendra Modi
Ø Amazon set for face-off with Mukesh Ambani's RIL for India retail dominance
Ø Aurobindo Pharma inks pact with New Mountain Capital to sell US-based unit for USD 550 mn
Ø India's crude steel output dips 3% to 8.5 MT in Sept: World Steel Assoc
Ø RBI encourages investment in sovereign bonds as part of liquidity measures
Ø Sebi plan to introduce capital adequacy norms rattles stockbrokers
Ø PNB scam: London court rejects Nirav Modi's bail application for 7th time
Ø Divestment of US subsidiary to leave Aurobindo Pharma cash positive
Business Line
Mint
Ø DIPAM to monetise assets worth over ₹100 crore
Ø Production from JV with Reliance to represent 15% of India’s gas demand: bp
Ø Modi to meet global funds on November 5, invite investments into India
Ø CDSL Q2 profit after tax surges 68% to ₹48.87 crore
Ø Ant Group IPO pricing ‘history's largest’: Alibaba's Jack Ma
Ø Lenders ask DHFL's bidders to sweeten their bids by 31 Oct
Ø Torrent Pharma Q2 net profit up 27% at ₹310 crore
Ø Paytm Money launches ETFs, aims for investment by 1 lakh users in 12-18 months
Ø Oil drops on rising virus cases, increasing Libyan output
Ø Top global IT company's market cap erodes by $33 bn due to trimmed outlook
Financial Express
DNA
Ø BP eyes India's fuel market, wants gas in GST
Ø Economic, oil demand recovery around the corner with development of COVID-19 vaccine: OPEC
Ø Capex: PMO asks 13 oil PSUs to double FY21 spend to Rs 2 lakh crore
Ø GHCL Q2 net profit down 27.7 pc to Rs 85 cr
Ø PM Modi to inaugurate National Conference on Vigilance and Anti Corruption
Ø Bharat Biotech's COVAXIN receives nod for third phase of human trial
By: via @AlliesFin Serve Stock Market
